학술논문
Efficacy and safety of secukinumab in moderate to severe palmoplantar pustular psoriasis over 148 weeks: Extension of the 2PRECISE study
Document Type
Short Communication
Author
Source
In Journal of the American Academy of Dermatology February 2021 84(2):552-554
Subject
Language
ISSN
0190-9622